Jean-pierre Bizzari, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 35,000 shares at $41.01 ($1.4M) on 2021-08-25, disclosed to the SEC on 2021-08-25.
Open-market sale of $1.4M HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.